Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RBPMS2 pseudogene 1 (RBPMS2P1) is a genomic DNA segment with high sequence similarity to the RBPMS2 gene, but it is annotated as a **pseudogene**. Pseudogenes are typically non-functional due to mutations or lack of regulatory elements required for expression. Unlike the functional RBPMS2 gene, which encodes an RNA-binding protein involved in smooth muscle differentiation and splicing regulation[1][4][5], RBPMS2P1 does not encode a known protein, does not belong to receptor or enzyme classes, and is not considered a therapeutic target. No clinical or biological significance is established for RBPMS2P1. There is nothing to suggest RBPMS2P1 is a valid therapeutic target, receptor, or gene with actionable functions. If you are seeking information on the **RBPMS2 gene** (RNA Binding Protein, mRNA Processing Factor 2), which is a protein-coding gene, see "RBPMS2" instead[1][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RBPMS2 pseudogene 1 (RBPMS2P1).